Imanova is a world- leading expert in imaging sciences and their application to the understanding of disease and translational drug development. Our industry expertise and extensive links with clinicians and scientists in academia provide unrivalled capabilities to facilitate drug development.
Imanova has the state-of-the-art technology and skills to provide companies with quantitative data to accurately predict the effectiveness of a drug within human earlier within the drug development process, ensuring the resources are used efficiently and effectively.
Our services include the development of novel Imaging Biomarkers, Clinical Imaging Services (PET and MRI), Preclinical Imaging Services, Analysis and Consultancy Services. We have the knowledge, experience and the expertise to provide end-to-end support to clients and collaborators.